Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 22066 AL 22080

Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets

Borroni B, Agosti C, Marcello E, Di Luca M, Padovani A.

Exp Gerontol. 2010 Jan;45(1):53-6. doi: 10.1016/j.exger.2009.08.004. Epub 2009 Aug 21.

Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease

Fiala M, Veerhuis R.

Exp Gerontol. 2010 Jan;45(1):57-63. doi: 10.1016/j.exger.2009.08.003. Epub 2009 Aug 21.

Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice

Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L.

Neurobiol Dis. 2010 Feb;37(2):294-306. doi: 10.1016/j.nbd.2009.09.004. Epub 2009 Sep 23.

Blood-based biomarkers of microvascular pathology in Alzheimer's disease

Ewers M, Mielke MM, Hampel H.

Exp Gerontol. 2010 Jan;45(1):75-9. doi: 10.1016/j.exger.2009.09.005. Epub 2009 Sep 24.

Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects

Cedazo-Minguez A, Winblad B.

Exp Gerontol. 2010 Jan;45(1):5-14. doi: 10.1016/j.exger.2009.09.008. Epub 2009 Sep 29.

Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications

Ho L, Fivecoat H, Wang J, Pasinetti GM.

Exp Gerontol. 2010 Jan;45(1):15-22. doi: 10.1016/j.exger.2009.09.007. Epub 2009 Sep 29.

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, Trojanowski JQ, Blennow K.

Exp Neurol. 2010 Jun;223(2):334-46. doi: 10.1016/j.expneurol.2009.09.024. Epub 2009 Oct 6.

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

Hampel H, Blennow K, Shaw LM, Hoessler YC, Zetterberg H, Trojanowski JQ.

Exp Gerontol. 2010 Jan;45(1):30-40. doi: 10.1016/j.exger.2009.10.010. Epub 2009 Oct 22.

Origins, controversies and recent developments of the MCI construct

Gainotti G.

Curr Alzheimer Res. 2010 May;7(3):271-9. doi: 10.2174/156720510791050858.

Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease

Schmand B, Huizenga HM, van Gool WA.

Psychol Med. 2010 Jan;40(1):135-45. doi: 10.1017/S0033291709991516. Epub 2009 Oct 29.

Protein kinase C as a peripheral biomarker for Alzheimer's disease

de Barry J, Liégeois CM, Janoshazi A.

Exp Gerontol. 2010 Jan;45(1):64-9. doi: 10.1016/j.exger.2009.10.015. Epub 2009 Nov 4.

Editorial to biomarkers of Alzheimers disease and dementia in cerebrospinal fluid and blood

Humpel C.

Exp Gerontol. 2010 Jan;45(1):1. doi: 10.1016/j.exger.2009.11.001. Epub 2009 Nov 6.

Decreased C-reactive protein levels in Alzheimer disease

O'Bryant SE, Waring SC, Hobson V, Hall JR, Moore CB, Bottiglieri T, Massman P, Diaz-Arrastia R.

J Geriatr Psychiatry Neurol. 2010 Mar;23(1):49-53. doi: 10.1177/0891988709351832. Epub 2009 Nov 20.

Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls

von Känel R, Ancoli-Israel S, Dimsdale JE, Mills PJ, Mausbach BT, Ziegler MG, Patterson TL, Grant I.

Gerontology. 2010;56(1):41-50. doi: 10.1159/000264654. Epub 2009 Dec 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias